Interested in becoming an advocate?
Back to main page
Rybelsus®
Daily oral pill
Ozempic (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.
Rybelsus (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.
How does
Rybelsus®
work:
- act on brain signaling to reduce food intake
- helps control blood sugar levels by increasing the release of insulin from the pancreas
- slows down food leaving your stomach, thus, keeping you fuller for longer
Common side effects of
Rybelsus®
- nausea
- vomiting
- decreased appetite
- diarrhea
- stomach (abdominal) pain
- constipation
You can find more information here:
Expected Results:
- Helps control blood sugar levels
- Decreased HgbA1C
- Although Rybelsus hasn’t been FDA approved for weight loss, adults with type 2 diabetes on Rybelsus lost on average 4-7 lbs, depending on the dosage
Do not take
Rybelsus®
if you:
- have or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have MEN2
- are pregnant, planning to become pregnant or breastfeeding
- have or have had history of pancreatitis
- have a history of gastroparesis or IBD
- are allergic to semaglutide or any of the ingredients* in Rybelsus
*non-medicinal ingredients in Rybelsus: magnesium stearate, microcrystalline cellulose, povidone K 90, salcaprozate sodium (SNAC)
Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.